Long‐term cost‐effectiveness of invasive urodynamic studies for overactive bladder in women
The use of UDS in women with a diagnosis of OAB and whose condition is refractory to initial medical and conservative treatments is unlikely to be cost-effective when examined from a UK perspective and with a lifetime horizon. Despite having access to the FUTURE study data, the parameterisation of the model is limited by the current evidence base. An ongoing long-term follow-up study will help reduce these uncertainties.
Authors
- Graeme MacLennan (ORCID: https://orcid.org/0000-0002-1039-5646)
- Helen Bell‐Gorrod (ORCID: https://orcid.org/0000-0001-8054-8073)
- Suzanne Breeman (ORCID: https://orcid.org/0000-0001-9950-7079)
- Praveen Thokala (ORCID: https://orcid.org/0000-0003-4122-2366)
- David Cooper (ORCID: https://orcid.org/0000-0002-9361-4399)
- Simon Dixon (ORCID: https://orcid.org/0000-0001-7394-7009)
- Mohamed Abdel‐Fattah (ORCID: https://orcid.org/0000-0002-8290-0613)
Institutions
- University of Aberdeen (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1111/bju.16703
- Citations
- 3
- Primary Topic
- Pelvic floor disorders treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.00
Funders
- National Institute for Health and Care Research
- Health Technology Assessment Programme